Literature DB >> 22662285

Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Chalermrat Bunchorntavakul1, Disaya Chavalitdhamrong.   

Abstract

Cirrhotic patients are immunocompromised with a high risk of infection. Proinflammatory cytokines and hemodynamic circulation derangement further facilitate the development of serious consequences of infections. Other than spontaneous bacterial peritonitis, bacteremia and bacterial infections of other organ systems are frequently observed. Gram-negative enteric bacteria are the most common causative organism. Other bacterial infections, such as enterococci, Vibrio spp., Aeromonas spp., Clostridium spp., Listeria monocytogenes, Plesiomonas shigelloides and Mycobacterium tuberculosis are more prevalent and more virulent. Generally, intravenous third generation cephalosporins are recommended as empirical antibiotic therapy. Increased incidences of gram-positive and drug-resistant organisms have been reported, particularly in hospital-acquired infections and in patients receiving quinolones prophylaxis. This review focuses upon epidemiology, microbiology, clinical features and treatment of infections in cirrhosis other than spontaneous bacterial peritonitis, including pathogen-specific and liver disease-specific issues.

Entities:  

Keywords:  Bacterial infection; Cirrhosis

Year:  2012        PMID: 22662285      PMCID: PMC3365435          DOI: 10.4254/wjh.v4.i5.158

Source DB:  PubMed          Journal:  World J Hepatol


  107 in total

1.  Clinical impact of influenza immunization in patients with liver cirrhosis.

Authors:  Joon Young Song; Hee Jin Cheong; Seok Hoon Ha; In Sook Hwang; Sae Yoon Kee; Hye Won Jeong; Chang Gyu Lee; Woo Joo Kim
Journal:  J Clin Virol       Date:  2007-06-07       Impact factor: 3.168

2.  Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage.

Authors:  J Goulis; A Armonis; D Patch; C Sabin; L Greenslade; A K Burroughs
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

3.  Antibiotic prophylaxis for GI endoscopy.

Authors:  Subhas Banerjee; Bo Shen; Todd H Baron; Douglas B Nelson; Michelle A Anderson; Brooks D Cash; Jason A Dominitz; S Ian Gan; M Edwyn Harrison; Steven O Ikenberry; Sanjay B Jagannath; David Lichtenstein; Robert D Fanelli; Ken Lee; Trina van Guilder; Leslie E Stewart
Journal:  Gastrointest Endosc       Date:  2008-03-28       Impact factor: 9.427

4.  Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema.

Authors:  Eva Sese; Xavier Xiol; Jose Castellote; Eva Rodríguez-Fariñas; Gemma Tremosa
Journal:  J Clin Gastroenterol       Date:  2003-01       Impact factor: 3.062

5.  Risk and case fatality rate of meningitis in patients with liver cirrhosis.

Authors:  I Mølle; A M Thulstrup; N Svendsen; H C Schønheyder; H T Sørensen
Journal:  Scand J Infect Dis       Date:  2000

6.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

7.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Authors:  Vasiliki Arvaniti; Gennaro D'Amico; Giuseppe Fede; Pinelopi Manousou; Emmanuel Tsochatzis; Maria Pleguezuelo; Andrew Kenneth Burroughs
Journal:  Gastroenterology       Date:  2010-06-14       Impact factor: 22.682

Review 8.  Immune dysfunction and infections in patients with cirrhosis.

Authors:  Alexander R Bonnel; Chalermrat Bunchorntavakul; K Rajender Reddy
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-11       Impact factor: 11.382

9.  Community-acquired bacterial meningitis in cirrhotic patients.

Authors:  C Cabellos; P F Viladrich; J Ariza; J-M Maiques; R Verdaguer; F Gudiol
Journal:  Clin Microbiol Infect       Date:  2007-11-13       Impact factor: 8.067

10.  A prospective evaluation of bacteremic patients with chronic liver disease.

Authors:  P F Barnes; C Arevalo; L S Chan; S F Wong; T B Reynolds
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425

View more
  19 in total

1.  Appropriate empirical antibiotic use and 30-d mortality in cirrhotic patients with bacteremia.

Authors:  Hyun Park; Ki Jun Jang; Won Jang; Sang Hoon Park; Ji Young Park; Tae Joo Jeon; Tae Hoon Oh; Won Chang Shin; Won-Choong Choi; Dong Hyun Sinn
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 2.  Bacterial infections in cirrhosis: A critical review and practical guidance.

Authors:  Chalermrat Bunchorntavakul; Naichaya Chamroonkul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2016-02-28

3.  Mycobacterium tuberculosis bacteremia in a human immunodeficiency virus-negative patient with liver cirrhosis: A case report.

Authors:  Zhe-Zhe Lin; Dan Chen; Sai Liu; Jian-Hua Yu; Shou-Rong Liu; Ming-Li Zhu
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

4.  Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

Authors:  R K Kelley; H S Nimeiri; P N Munster; M T Vergo; Y Huang; C-M Li; J Hwang; M F Mulcahy; B M Yeh; P Kuhn; M S Luttgen; J A Grabowsky; L Stucky-Marshall; W M Korn; A H Ko; E K Bergsland; A B Benson; A P Venook
Journal:  Ann Oncol       Date:  2013-03-21       Impact factor: 32.976

5.  Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.

Authors:  Philipp Lutz; Marijo Parcina; Isabelle Bekeredjian-Ding; Hans Dieter Nischalke; Jacob Nattermann; Tilman Sauerbruch; Achim Hoerauf; Christian P Strassburg; Ulrich Spengler
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

6.  Septic shock due to Aeromonas hydrophila bacteremia in a patient with alcoholic liver cirrhosis: a case report.

Authors:  Tetsuya Yumoto; Shingo Ichiba; Nao Umei; Sunao Morisada; Kohei Tsukahara; Keiji Sato; Toyomu Ugawa; Yoshihito Ujike
Journal:  J Med Case Rep       Date:  2014-12-03

Review 7.  Immune Dysfunction in Cirrhosis.

Authors:  Mohd Talha Noor; Piyush Manoria
Journal:  J Clin Transl Hepatol       Date:  2017-03-10

Review 8.  Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.

Authors:  Toru Shizuma
Journal:  World J Hepatol       Date:  2018-02-27

Review 9.  A current update on the rule of alternative and complementary medicine in the treatment of liver diseases.

Authors:  Yong-Song Guan; Qing He
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-10       Impact factor: 2.629

10.  A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients.

Authors:  Cristina Lucidi; Vincenza Di Gregorio; Giancarlo Ceccarelli; Mario Venditti; Oliviero Riggio; Manuela Merli
Journal:  Clinicoecon Outcomes Res       Date:  2017-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.